MANUFACTURE OF DEGARELIX Russian patent published in 2018 - IPC A61K38/09 A61K47/12 A61K9/19 

Abstract RU 2657444 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to degarelix and methods for the manufacture of a medicinal product containing degarelix substance. Substance includes degarelix, acetic acid in an amount of 4.5 to 10.0% (w/w), water in an amount of 10% (w/w). After dissolution in water of 20 mg of degarelix as a free base and mannitol in an amount of 2.5 wt. %, the substance exhibits a viscosity of up to 3.2 mPa⋅C. Viscosity is measured with a viscometer with a cone-plane measuring system with D=60 mm and 1°. Shear rate is increased from 0 to 500 s-1 for 20 steps at a constant temperature of 20±0.2°C. Methods for the preparation of a medicament substance of degarelix and the manufacture of a lyophilized drug product of degarelix are also provided.

EFFECT: inventions make it possible to manufacture medical products with a viscosity and bioavailability that provides a sustained release of the active substance for several months depending on the dosage.

12 cl, 3 dwg, 2 tbl, 8 ex

Similar patents RU2657444C2

Title Year Author Number
METHOD OF PRODUCING BORTEZOMIB LYOPHILIZATE AND A PHARMACEUTICAL COMPOSITION CONTAINING BORTEZOMIB IN FORM OF A STABLE LYOPHILIZED PRODUCT OBTAINED BY SAID METHOD 2018
  • Nazarenko Anna Borisovna
  • Zakoriukin Nikolai Valentinovich
  • Kinasov Dmitrii Gurgenovich
RU2696854C1
PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM 2017
  • Seredenin Sergej Borisovich
  • Gudasheva Tatyana Aleksandrovna
  • Alekseev Konstantin Viktorovich
  • Blynskaya Evgeniya Viktorovna
  • Tishkov Sergej Valerevich
  • Mikheeva Anna Sergeevna
  • Povarnina Polina Yurevna
  • Durnev Andrej Dmitrievich
  • Zherdev Vladimir Pavlovich
RU2678203C2
BORTEZOMIB LYOPHILIZATE PRODUCTION METHOD AND THE BORTEZOMIB CONTAINING PHARMACEUTICAL COMPOSITION IN THE FORM OF STABLE LYOPHILIZATED PRODUCT PRODUCED BY SAID METHOD 2017
  • Nazarenko Anna Borisovna
  • Kinasov Dmitrij Gurgenovich
  • Ladygin Vyacheslav Vladimirovich
  • Kornev Kirill Olegovich
  • Zakoryukin Nikolaj Valentinovich
RU2659160C1
NEW METHOD FOR STABILIZATION OF A BIOPHARMACEUTICAL MEDICINAL PRODUCT IN MANUFACTURE THEREOF 2017
  • Scholz, Martin
  • Kemter, Kristina
  • Altrichter, Jens
  • Kriehuber, Thomas
RU2744630C2
LYOPHILISED FORMULATIONS OF BENDAMUSTINE HYDROCHLORIDE 2014
  • Turketta Stefano
  • Dzenoni Mauritsio
  • Brandi Paolo
RU2679614C2
SUSTAINED TYPE HUMAN GROWTH HORMONE PREPARATION 2014
  • Rim Hwa Peoung
  • Kim Hyun Uk
  • Im Ho Taek
  • Kim Sang Yun
  • Lim Hyung Kyu
  • Bae Sung Min
  • Kwon Se Chang
RU2683823C2
PHARMACEUTICAL COMPOSITION OF FUSION PROTEIN TACI-FC 2020
  • Xu, Qiaoyu
  • Li, Zhuanglin
  • Yao, Xuejing
  • Fang, Jianmin
RU2779387C1
LYOPHILISED COMPOSITIONS CCI-779 2004
  • Rubino Dzhozef T.
RU2345772C2
ECTEINASCIDIN AND DISACCHARIDE-CONTAINING COMPOSITIONS 2005
  • Kal'Vo Sal'Ve Pilar
  • Nejen Bastian
  • Bejnen Jakob Khendrik
  • Tobio Barrejra Marija
RU2382647C2
METHOD FOR OBTAINING GLATIRAMER ACETATE PRODUCT 2015
  • Cohen Rakefet
  • Habbah Sasson
  • Safadi Muhammad
RU2669769C2

RU 2 657 444 C2

Authors

Schwach Gregoire

Nilsson Anders

Gottschalk Boeving Tine Elisabeth

Rasmussen Jon Holbech

Mornstam Birgitta

Tsirk Anders

Annby Ulf

Fomsgaard Jens

Dates

2018-06-13Published

2013-05-31Filed